Max Salvatore (@maxsaltweets) 's Twitter Profile
Max Salvatore

@maxsaltweets

🤓 epi phd @umichsph. ehr-linked biobank research. #Rstats and data visualization. ⚽️🍝

ID: 1047179354462199808

calendar_today02-10-2018 17:39:48

671 Tweet

337 Followers

417 Following

The Lancet (@thelancet) 's Twitter Profile Photo

On the cover this week, the 2024 report of the The Lancet Countdown on Health and Climate Change on health & climate change. Read the report 👉 hubs.li/Q02XtMYP0 #LancetClimate24 Explore our latest issue 👉 hubs.li/Q02XtStG0

On the cover this week, the 2024 report of the <a href="/LancetCountdown/">The Lancet Countdown on Health and Climate Change</a> on health &amp; climate change.

Read the report 👉 hubs.li/Q02XtMYP0 #LancetClimate24
Explore  our latest issue 👉 hubs.li/Q02XtStG0
Eric Topol (@erictopol) 's Twitter Profile Photo

New NEJM A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of >2,500 participants with obesity, absolute reduction of 10/100 treated nejm.org/doi/full/10.10… by Ania M. Jastreboff, MD, PhD and

New <a href="/NEJM/">NEJM</a> 
A whopping (~90%) reduction of progression to Type 2 diabetes with tirzepatide (GLP-1 drug, dual receptor) vs placebo in a randomized trial of &gt;2,500 participants with obesity, absolute reduction of 10/100 treated
nejm.org/doi/full/10.10…
by <a href="/AniaJastreboff/">Ania M. Jastreboff, MD, PhD</a> and